Mary C. Zanarini, EdD

  • 18Articles
  • 110.2KReads
  • 2001–2024Active
  • 41Collaborators
  • 1.1KCitations

About

Mary C. Zanarini, EdD, is affiliated with McLean Hospital in Belmont, Massachusetts, and Harvard Medical School in Boston, Massachusetts. Since 2001, Zanarini has published extensively on borderline personality disorder, focusing on its long-term course, symptomatic remission, and recovery, as well as its interactions with mood and anxiety disorders. Research topics also include suicide, addiction, bipolar disorder, child and adolescent psychiatry, depression, neurodevelopmental issues, and neuroleptic malignant syndrome. Zanarini has contributed to studies on pharmacological treatments, psychoeducation, and resilience factors in personality disorders.

Publications

JCP
Symptomatic Remission and Overall Recovery From BPD
Original Research

Symptomatic Remission and Overall Recovery From BPD

October 23, 2024

Over 24 years, patients with BPD were significantly slower to achieve remission or recovery than patients with other personality disorders. Ultimately, however, both groups achieved similarly high rates of...
, , , et al
JCP
Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time
Original Research

Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time

August 7, 2024

Findings suggest that the absence of substance use disorders is the strongest predictor of achieving recovery from BPD.
, , , et al
JCP
Smoking in Borderline Patients
Original Research

Smoking in Borderline Patients

November 8, 2023

This study assessed predictors of smoking in borderline personality disorder and compared smoking prevalence in recovered vs non-recovered patients.
, , , et al
JCP
Original Research

Deaths in Borderline Personality Disorder Patients

January 22, 2019

Borderline personality disorder (BPD) is associated with increased suicidality, but less is known about other forms of premature death in individuals with BPD. Read this article to learn how...
, , , et al
JCP
Original Research

Psychoeducation for Borderline Personality Disorder

July 11, 2017

Although psychoeducation can benefit patients with borderline personality disorder, the lack of trained personnel and the cost of implementation have prevented widespread adoption of this treatment. Read this article...
, , , et al
JCP
Original Research

Impact of Borderline Personality on Anxiety

November 25, 2015

Read the full article on how borderline personality disorder affects the course of GAD, social phobia, and PTSD.
, , , et al
JCP
Original Research

Interactions of Borderline Personality Disorder and Mood Disorders Over 10 Years

June 10, 2014

, , , et al
JCP
Article

Psychiatric Comorbidity in Hospitalized Adolescents With Borderline Personality Disorder

May 15, 2014

, , , et al
JCP
Original Research

The Use of Prescription Opioid Medication by Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 10-Year Follow-Up Study

January 7, 2014

, ,
JCP
Original Research

Self-Harm Subscale of the Schedule for Nonadaptive and Adaptive Personality (SNAP): Predicting Suicide Attempts Over 8 Years of Follow-Up

November 15, 2011

, , , et al
JCP
Original Research

A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study

April 5, 2011

, , , et al
JCP
Article

Positive Childhood Experiences: Resilience and Recovery From Personality Disorder in Early Adulthood.

July 16, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe